Description: Human induced pluripotent stem cells (hiPSCs) have moved beyond research into application in clinical trials. However, only a limited number of clinical grade hiPSC lines are available. The aim of this project is to generate a clinical grade, safe iPSC line under GMP-compliant conditions as starting point for novel cell therapies.
